Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22063192 | 0.91 | ALDH1A1 (0.39) | ALDH1A1LMNASMN1; SMN2TP53NPC1 | |
| SCHEMBL22063194 | 0.88 | ALDH1A1 (0.38) | ALDH1A1LMNASMN1; SMN2TP53NPC1 | |
| SCHEMBL22062707 | 0.85 | KIF11 (0.42) | ALDH1A1LMNASMN1; SMN2TP53NPC1 | |
| SCHEMBL22063073 | 0.85 | ALDH1A1 (0.41) | ALDH1A1LMNASMN1; SMN2TP53NPC1 | |
| SCHEMBL22063070 | 0.84 | KDM4E (0.43) | ALDH1A1LMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL22088726 | 0.84 | ALDH1A1 (0.39) | ALDH1A1LMNASMN1; SMN2TP53NPC1 | |
| SCHEMBL22063058 | 0.84 | ALDH1A1 (0.39) | ALDH1A1LMNASMN1; SMN2TP53NPC1 | |
| SCHEMBL22063055 | 0.82 | SMN1; SMN2 (0.43) | ALDH1A1LMNASMN1; SMN2TP53ADORA2A | |
| SCHEMBL23763627 | 0.80 | ALDH1A1 (0.38) | ALDH1A1LMNASMN1; SMN2TP53NPC1 | |
| SCHEMBL22062740 | 0.79 | KDM4E (0.41) | ALDH1A1LMNASMN1; SMN2TP53ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | EMC2, NFE2L2, AOC2 | ALDH1A1 1970/4885LMNA 1641/4885SMN1; SMN2 3979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.